0 LIKES LikeUnLike
ok I've been hanging around this section for a bit now and find the arguments put forward by different regular members on here really interesting.one of them is that the demands of sceptics are skewed when they say they want hard evidence like double-blinded RCTs for AM as these cost so much money that only drug companies who can afford them by patenting therapies will get them. since a lot of AM therapies can't be patented, there isn't the money to get those kind of trials.and there's also the argument that AM can't be trialled because it accepts all the variables a patient presents with and provides holistic care that can't be mathematically reduced into a formula.since the sceptics/critics often reduce the argument to the onus being on AM to give the evidence that it works, do they see any problem with this?
Tags:
Report (0) (0) | earlier
Latest activity: earlier. This question has 6 answers.